Detalhe da pesquisa
1.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.
J Neurol Neurosurg Psychiatry
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744459
2.
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.
J Neurol Neurosurg Psychiatry
; 95(6): 544-553, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290838
3.
Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression.
J Neurol Neurosurg Psychiatry
; 94(7): 526-531, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732044
4.
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study.
Mult Scler
; 29(8): 1012-1023, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148166
5.
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clin Exp Immunol
; 206(3): 251-265, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080180
6.
Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.
Genet Med
; 18(9): 924-32, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820063
7.
A new era in the treatment of multiple sclerosis.
Med J Aust
; 203(3): 139-41, 141e.1, 2015 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224184
8.
Longlook: initial outcomes of a longitudinal integrated rural clinical placement program.
Aust J Rural Health
; 23(3): 169-75, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981882
9.
Modelling genetic susceptibility to multiple sclerosis with family data.
Neuroepidemiology
; 40(1): 1-12, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075677
10.
Role of trigeminal microvascular decompression in the treatment of SUNCT and SUNA.
Curr Pain Headache Rep
; 17(5): 332, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564233
11.
Multiple sclerosis: from molecules to treatment.
Int J Mol Sci
; 14(4): 7598-602, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23612323
12.
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort study.
Sci Rep
; 13(1): 11584, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463930
13.
What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?
Int J Mol Sci
; 13(10): 12665-709, 2012 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23202920
14.
Molecular pathogenesis of neuromyelitis optica.
Int J Mol Sci
; 13(10): 12970-93, 2012 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23202933
15.
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis.
Mult Scler Relat Disord
; 59: 103511, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093841
16.
Effects of cannabinoids in Parkinson's disease animal models: a systematic review and meta-analysis.
BMJ Open Sci
; 6(1): e100302, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618606
17.
Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
J Parkinsons Dis
; 12(2): 495-508, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958046
18.
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.
J Neurol
; 269(2): 836-845, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213614
19.
Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis.
Sci Rep
; 12(1): 19291, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369345
20.
Response to treatment in NMOSD: the Australasian experience.
Mult Scler Relat Disord
; 58: 103408, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216788